Meloxicam of solutions for injections 10 mg/ml to 1.5 ml, dexamethasone, solution for injection 4 mg/ ml, human insulin (medium duration of action), suspension for injetions 100 mg/ mL, vials 10 ml, insulin for human use (combination: 30% short...
TenderZenith matches this tender's eligibility criteria against your company profile to calculate a deterministic qualification score and identify potential disqualifiers.
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Description & Project Overview
Meloxicam of solutions for injections 10 mg/ml to 1.5 ml, dexamethasone, solution for injection 4 mg/ ml, human insulin (medium duration of action), suspension for injetions 100 mg/ mL, vials 10 ml, insulin for human use (combination: 30% short duration; 70% medium durations), suspensions for injeations 100 mg / mL; cartridges 3 ml, levothyroxine tablets 100 mg, levoxyroxene tablets 50 mg, fish flavours 10 mg, tolvazole tablets with a closed fluid 150 mg, propolis, propolol, 10 mg of alcohol, 10 ml of cartridge, 40 mg of water, 40 ml of water and 40 ml, 40 g of water for propolis (propolis, 40 mm of water), 40 mg, 40 mL of water to 40 mg (propol, 40 μl of water)10 ml, sulphametosazole/trimethoprim tablets of 400 mg/80 mg, solution of lipoic acid for infusions, 30 mg/ml of 20 ml, barbiturates in combination (ethyl ether of a-bromiza-leureic acid 12,42 mg, phenobarbital 11,34 mg, menthol pH in the menthol ether and isolearic acid 46 mg) in capsules
Related Procurement Opportunities
Similar tenders in Pharmaceuticals, Healthcare and Medicine, Chemicals